Analysis of incidence and mortality of male urogenital system tumors in China from 1990 to 2019
10.3760/cma.j.cn371439-20240509-00106
- VernacularTitle:1990—2019年中国男性泌尿生殖系统肿瘤发病和死亡分析
- Author:
Mingjun ZHAO
1
;
Chunhu YU
Author Information
1. 首都医科大学附属北京康复医院泌尿与代谢康复中心，北京 110107
- Keywords:
Urogenital neoplasms;
Kidney neoplasms;
Urinary bladder neoplasms;
Prostatic neoplasms;
Testicular neoplasms;
Incidence;
Mortality
- From:
Journal of International Oncology
2024;51(10):632-638
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To examine the prevalence and trends of male urogenital system tumors in China from 1990 to 2019.Methods:The Global Burden of Disease Study 2019 database was used to analyze the incidence and mortality of male urogenital tumors among different age groups and years in China. Joinpoint 5.2.0 software was utilized to analyze the incidence and mortality trends of male urogenital tumors in China from 1990 to 2019. Standardized incidence and mortality rates of male urogenital system tumors in China, in the world and in different sociodemographic index (SDI) regions were compared.Results:In 2019, the rank of incidence of male urogenital system tumors in China from high to low was prostate cancer (21.17/100 000), bladder cancer (11.41/100 000), kidney cancer (5.87/100 000) and testicular cancer (2.37/100 000). The rank of mortality was consistent with the rank of incidence, which was prostate cancer (7.50/100 000), bladder cancer (4.35/100 000), kidney cancer (2.33/100 000) and testicular cancer (0.17/100 000). The ranks of incidence and mortality of male urogenital tumors in China in 1990 were the same as those in 2019. In 2019, prostate cancer cases began to appear in the 20-year-old age group, bladder cancer cases in the 15-year-old age group, while kidney cancer and testicular cancer cases began to emerge in the 1-4-year-old age group. Before the age of 55, the incidence and mortality rates of four types of tumors in the male urogenital system did not differ significantly. After the age of 55, the incidence and mortality rate of prostate cancer surpassed those of kidney cancer, bladder cancer and testicular cancer. The incidence rate of male urogenital tumors in 2019 was higher in all age groups than in 1990. From 1990 to 2019, the incidence, mortality and standardized incidence rates of prostate cancer, bladder cancer, kidney cancer and testicular cancer all showed increasing trends. The standardized mortality rate of kidney cancer showed an upward trend, while prostate cancer exhibited a downward trend. Compared with global averages, the standardized incidence and mortality rates of male urogenital system tumors in China were lower in 1990 and 2019. Compared with different SDI regions, the standardized incidence and mortality rates of male kidney cancer, testicular cancer and bladder cancer in China in 1990 and 2019 were similar to those in moderate and low SDI regions. The standardized incidence and mortality rates of prostate cancer in 1990 and 2019 were lower in China than in different SDI regions.Conclusion:In 1990 and 2019, the incidence and mortality ranks of male urogenital tumors in China are the same, with prostate cancer, bladder cancer, kidney cancer and testicular cancer in order from high to low. From 1990 to 2019, the incidence, mortality and standardized incidence rates of male urogenital system tumors in China show increasing trends. In 1990 and 2019, compared with the global average, the standardized incidence and mortality rates of male urogenital system tumors in China are lower.
